Cubist Systematic Strategies, LLC Amgen Inc Call Options Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $649,698 - $708,498	2,100 Added 15.22%	15,900 $5.12 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $7.04 Million - $8.56 Million	-26,800 Reduced 66.01%	13,800 $4.31 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $2.42 Million - $2.92 Million	-9,000 Reduced 18.15%	40,600 $11.5 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $1.1 Million - $1.24 Million	-4,300 Reduced 7.98%	49,600 $14.3 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $1.07 Million - $1.33 Million	4,900 Added 10.0%	53,900 $14.5 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $5.87 Million - $6.94 Million	-27,400 Reduced 35.86%	49,000 $10.9 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $5.31 Million - $6.47 Million	23,500 Added 44.42%	76,400 $18.5 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $3.32 Million - $4.22 Million	14,500 Added 37.76%	52,900 $13.9 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $3.91 Million - $4.4 Million	17,400 Added 82.86%	38,400 $8.66 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $4.84 Million - $5.39 Million	21,000 New	21,000 $5.11 Million

3,113

410M

6.15M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.